Trials / Completed
CompletedNCT02834442
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects
A Randomised, Double Blind, Placebo Controlled Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of MT-7117 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-7117 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-7117 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-07-15
- Last updated
- 2017-07-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02834442. Inclusion in this directory is not an endorsement.